Is it safe to undergo living donor kidney transplant within 2 weeks following COVID-19?

Author:

Kute Vivek B.ORCID,Chauhan Sanshriti,Ray Deepak Shankar,Hegde Umapati,Sinha Vijay Kumar,Das Sushree Sashmita,Godara Suraj,Anandh UrmilaORCID,Gulati Sanjeev,Goswami Jitendra,Dalal Sonal,Babu Kishor,Siddini Vishwanath,Patil Mayur,Meshram Hari ShankarORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Public Health, Environmental and Occupational Health

Reference5 articles.

1. ISOT consensus statement for the kidney transplant recipient and living donor with a previous diagnosis of COVID-19;Kute;Indian J Nephrol,2022

2. A multicenter cohort study from India of 75 kidney transplants in recipients recovered after COVID-19;Kute;Transplantation,2021

3. Management strategies and outcomes in renal transplant recipients recovering from COVID-19: a retrospective, multicentre, cohort study;Kute;EClinicalMedicine,2022

4. Guidance on coronavirus disease 2019 (COVID-19) for transplant clinicians,2020

5. Long-term outcomes of renal transplants from spousal and living-related and other living-unrelated donors: a single center experience;Kute;J Assoc Physicians India,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3